[1] CAMPBELL B C V, KHATRI P. Stroke[J]. Lancet,2020,396(10244):129-142. doi:  10.1016/S0140-6736(20)31179-X
[2] WANG S N, MIAO C Y. Targeting NAMPT as a therapeutic strategy against stroke[J]. Stroke Vasc Neurol,2019,4(2):83-89. doi:  10.1136/svn-2018-000199
[3] WANG P, MIAO C Y. NAMPT as a therapeutic target against stroke[J]. Trends Pharmacol Sci,2015,36(12):891-905. doi:  10.1016/j.tips.2015.08.012
[4] REVOLLO J R, GRIMM A A, IMAI S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells[J]. J Biol Chem,2004,279(49):50754-50763. doi:  10.1074/jbc.M408388200
[5] CHEN F, WENG Z, XIA Q, et al. Intracerebroventricular delivery of recombinant NAMPT deters inflammation and protects against cerebral ischemia[J]. Transl Stroke Res,2019,10(6):719-728. doi:  10.1007/s12975-019-00692-0
[6] ZHU T, XIE W J, WANG L, et al. Notoginsenoside R1 activates the NAMPT-NAD+-SIRT1 cascade to promote postischemic angiogenesis by modulating Notch signaling[J]. Biomed Pharmacother,2021,140:111693. doi:  10.1016/j.biopha.2021.111693
[7] WANG X, LI H, DING S. Pre-B-cell colony-enhancing factor protects against apoptotic neuronal death and mitochondrial damage in ischemia[J]. Sci Rep,2016,6:32416. doi:  10.1038/srep32416
[8] HOUTKOOPER R H, CANTÓ C, WANDERS R J, et al. The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways[J]. Endocr Rev,2010,31(2):194-223. doi:  10.1210/er.2009-0026
[9] LIU J, CHE X, YOU J, et al. Intracellular Nampt impairs esophageal squamous cell carcinoma neo-adjuvant chemotherapy response independent of eNampt[J]. Am J Transl Res,2021,13(3):1411-1421.
[10] DAKROUB A, NASSER S A, YOUNIS N, et al. Visfatin: a possible role in cardiovasculo-metabolic disorders[J]. Cells,2020,9(11):2444. doi:  10.3390/cells9112444
[11] ZHOU L, ZHANG S, BOLOR-ERDENE E, et al. NAMPT/SIRT1 attenuate ang II-induced vascular remodeling and vulnerability to hypertension by inhibiting the ROS/MAPK pathway[J]. Oxidative Med Cell Longev,2020,2020:1974265.
[12] ZHAO Y, LIU X Z, TIAN W W, et al. Extracellular visfatin has nicotinamide phosphoribosyltransferase enzymatic activity and is neuroprotective against ischemic injury[J]. CNS Neurosci Ther,2014,20(6):539-547. doi:  10.1111/cns.12273
[13] LU L F, YANG S S, WANG C P, et al. Elevated visfatin/pre-B-cell colony-enhancing factor plasma concentration in ischemic stroke[J]. J Stroke Cerebrovasc Dis,2009,18(5):354-359. doi:  10.1016/j.jstrokecerebrovasdis.2009.01.003
[14] ŠKOP V, KONTROVÁ K, ZÍDEK V, et al. Autocrine effects of visfatin on hepatocyte sensitivity to insulin action[J]. Physiol Res,2010:615-618. doi:  10.33549/physiolres.931845
[15] GARTEN A, PETZOLD S, BARNIKOL-OETTLER A, et al. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes[J]. Biochem Biophys Res Commun,2010,391(1):376-381. doi:  10.1016/j.bbrc.2009.11.066
[16] DALL M, TRAMMELL S A J, ASPING M, et al. Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity[J]. J Biol Chem,2019,294(36):13304-13326. doi:  10.1074/jbc.RA118.006756
[17] LONGA E Z, WEINSTEIN P R, CARLSON S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke,1989,20(1):84-91. doi:  10.1161/01.STR.20.1.84
[18] YOON M J, YOSHIDA M, JOHNSON S, et al. SIRT1-mediated eNAMPT secretion from adipose tissue regulates hypothalamic NAD+ and function in mice[J]. Cell Metab,2015,21(5):706-717. doi:  10.1016/j.cmet.2015.04.002
[19] MOSCHEN A R, GERNER R, SCHROLL A, et al. A key role for Pre-B cell colony-enhancing factor in experimental hepatitis[J]. Hepatology,2011,54(2):675-686. doi:  10.1002/hep.24416